EXO Baekhyun's Smoking Controversy in Macau Restaurant Apology

Sep.18.2024
EXO Baekhyun's Smoking Controversy in Macau Restaurant Apology
EXO's Baekhyun sparks controversy for smoking in a Macao restaurant, leading to a public apology from his agency.

According to a report by CNA Lifestyle on September 18th, Baekhyun, a member of the famous South Korean boy group EXO, sparked controversy after being photographed smoking in a restaurant in Macau, China.

EXO Baekhyun's Smoking Controversy in Macau Restaurant Apology
The video of Byun Baekhyun smoking an e-cigarette inside a restaurant in Macau was exposed on X. | Image source: X.


On September 16th, a video was exposed on X showing EXO's Baekhyun smoking an e-cigarette inside a restaurant in Macau, China. In the video, Baekhyun was seen smoking in a corner while chatting with several individuals who appeared to be staff members.

EXO Baekhyun's Smoking Controversy in Macau Restaurant Apology
SM Entertainment, the agency representing Byun Baekhyun, released an apology statement. Image source: X


According to the laws of Macau, individuals are not allowed to bring e-cigarettes into the territory and smoking is prohibited in all indoor areas except for designated smoking rooms.


On September 16th, the management company INB100, representing Byun Baekhyun, issued a public apology statement through its social media. The company explained that the video was filmed after his concert in Macau in June this year, and that neither he nor the staff were aware of the prohibition of e-cigarettes in Macau, China.


The statement reads as follows:


Hello, I am INB100.


We apologize to everyone who felt uncomfortable about the recent controversy involving our artist, Baekhyun, smoking indoors.


At the time, Baekhyun and our staff were completely unaware that smoking e-cigarettes was prohibited in Macau. After Baekhyun and the staff finished their performance in Macau, they went out for dinner. As the conversation unfolded, Baekhyun unintentionally smoked an e-cigarette.


Due to his careless actions, Baekhyun deeply apologizes for disappointing many fans.


Baekhyun and our company will be more vigilant to ensure that such incidents do not happen again, and pledge not to disappoint fans in the future. We will also strive to behave in a more mature manner.


We once again express our sincere apologies for any concerns and discomfort we may have caused you.


We are truly sorry.


A few months ago, Blackpink member Jennie faced criticism after being photographed using an e-cigarette indoors.


According to reports, Byun Baekhyun debuted as a member of the South Korean boy group EXO in 2012 and has been very popular since his debut. EXO is divided into two sub-units, EXO-K and EXO-M, which promote in South Korea and China respectively. Wu Yifan (Kris), Lu Han, and Huang Zitao (Tao) were former members of EXO-M but left the group later due to personal reasons.


We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Product | Full-screen display and 10K puffs: IVG launches new Pro-series pod vape in the UK
Product | Full-screen display and 10K puffs: IVG launches new Pro-series pod vape in the UK
E-cigarette brand IVG has recently rolled out the IVG Pro 2 across several UK online retailers. The device is compatible with IVG Pro pods and comes in 33 flavours with nicotine strengths of 0mg, 10mg and 20mg. Channel listings show a 2ml prefilled pod paired with a 10ml refill container, with pricing around £9.99.
Feb.02 by 2FIRSTS.ai
Product | 22ml Combined E-Liquid Supply, Rated for 35,000 Puffs: OXBAR Launches the OX35K Open-System Pod Device
Product | 22ml Combined E-Liquid Supply, Rated for 35,000 Puffs: OXBAR Launches the OX35K Open-System Pod Device
The vaping brand OXBAR has recently listed its open-system, refillable pod device OX35K on its official website. The product features a “2ml built-in pod + two 10ml external refill bottles” e-liquid supply structure and supports top refilling, with a claimed puff count of up to 35,000. It is equipped with a 1000mAh built-in battery and offers dual power modes—BOOST and ECO—positioning the device to balance high-puff performance with an open-system form factor.
Jan.13 by 2FIRSTS.ai
Korea’s MFDS sets 2026 plan to manage and disclose harmful constituents in tobacco products
Korea’s MFDS sets 2026 plan to manage and disclose harmful constituents in tobacco products
South Korea’s Ministry of Food and Drug Safety (MFDS) said it has established its 2026 work plan to systematically manage harmful constituents in tobacco products and disclose related information under the Tobacco Harmfulness Management Act, which took effect in November 2025.
Jan.16 by 2FIRSTS.ai
 Breaking News | FDA Adds on! Plus Nicotine Pouches to PMTA-Authorized List
Breaking News | FDA Adds on! Plus Nicotine Pouches to PMTA-Authorized List
The U.S. Food and Drug Administration (FDA) has added ON! Plus nicotine pouch products to its list of authorized products, disclosing that the brand has received Marketing Granted Orders (MGO) through the Premarket Tobacco Product Application (PMTA) pathway. The update makes on! Plus the second nicotine pouch brand authorized via PMTA, following ZYN. As of publication, the FDA had not issued a separate press release on the decision.
News
Dec.20
Virginia appeals to the Fourth Circuit over partial block on flavored vape ban enforcement
Virginia appeals to the Fourth Circuit over partial block on flavored vape ban enforcement
Virginia has asked the Fourth Circuit to overturn a district court order that partially blocked enforcement of the commonwealth’s flavored vape ban. In a notice, the state told U.S. District Judge David J. Novak it seeks to upend his December ruling that Virginia’s Chapter 23.2 statute is preempted by the Food, Drug and Cosmetic Act and the Family Smoking Prevention and Tobacco Control Act.
Jan.12 by 2FIRSTS.ai
FDA Outlines Manufacturing Requirements as Critical to ENDS PMTA Success
FDA Outlines Manufacturing Requirements as Critical to ENDS PMTA Success
FDA officials said manufacturing consistency is a core prerequisite for ENDS PMTA reviews, not a procedural formality. During its February 10, 2026 roundtable, the agency outlined expectations for quality management systems, manufacturing documentation, nicotine control, stability studies, and risk mitigation, emphasizing that robust manufacturing evidence underpins determinations of whether products are appropriate for the protection of public health.
Feb.11